Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittlin

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansNicholas A Malmquist, Sandeep Sundriyal, Joachim Caron, et al.
Journal of Medicinal Chemistry|February 11, 2026
Identification of Compound <b>15</b> (MMV1581361) as a <i>Pf</i>ATP4 Inhibitor with Transmission-Blocking Activity and <i>In Vivo</i> Efficacy in a SCID Mouse Model of MalariaHenry A Onyame, Stephen Brand, Delphin Baud, et al.
Journal of Medicinal Chemistry|January 18, 2017
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse ModelKawaljit Singh, John Okombo, Christel Brunschwig, et al.
Journal of Medicinal Chemistry|March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potentialYassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Evaluation of 4-Amino 2-Anilinoquinazolines against <i>Plasmodium</i> and Other Apicomplexan Parasites <i>In Vitro</i> and in a <i>P. falciparum</i> Humanized NOD-<i>scid</i> IL2Rγ<sup>null</sup> Mouse Model of MalariaPaul R Gilson, William Nguyen, William A Poole, et al.
Journal of Medicinal Chemistry|January 5, 2017
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)Yuxiang Dong, Xiaofang Wang, Sriraghavan Kamaraj, et al.
The Journal of Biological Chemistry|June 12, 2013
UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cellsRalf Brunner, Caroline L Ng, Hamed Aissaoui, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Mbio|May 8, 2024
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activityRebecca C S Edgar, Tess R Malcolm, Ghizal Siddiqui, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humansNicholas A Malmquist, Sandeep Sundriyal, Joachim Caron, et al.
Journal of Medicinal Chemistry|February 11, 2026
Identification of Compound <b>15</b> (MMV1581361) as a <i>Pf</i>ATP4 Inhibitor with Transmission-Blocking Activity and <i>In Vivo</i> Efficacy in a SCID Mouse Model of MalariaHenry A Onyame, Stephen Brand, Delphin Baud, et al.
Journal of Medicinal Chemistry|January 18, 2017
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse ModelKawaljit Singh, John Okombo, Christel Brunschwig, et al.
Journal of Medicinal Chemistry|March 7, 2012
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potentialYassir Younis, Frederic Douelle, Tzu-Shean Feng, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Evaluation of 4-Amino 2-Anilinoquinazolines against <i>Plasmodium</i> and Other Apicomplexan Parasites <i>In Vitro</i> and in a <i>P. falciparum</i> Humanized NOD-<i>scid</i> IL2Rγ<sup>null</sup> Mouse Model of MalariaPaul R Gilson, William Nguyen, William A Poole, et al.
Journal of Medicinal Chemistry|January 5, 2017
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)Yuxiang Dong, Xiaofang Wang, Sriraghavan Kamaraj, et al.
The Journal of Biological Chemistry|June 12, 2013
UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cellsRalf Brunner, Caroline L Ng, Hamed Aissaoui, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Mbio|May 8, 2024
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activityRebecca C S Edgar, Tess R Malcolm, Ghizal Siddiqui, et al.
Pageof 32